Nanox (NASDAQ: NNOX) has signed a distribution agreement with Costa Rica-based medical equipment distributor SOLME RC, S.A. to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. The agreement positions Nanox to enter its third Latin American market this year, following Argentina and Peru, signaling a strategic push into regions where advanced imaging infrastructure is often limited.
Under the agreement, SOLME will oversee marketing, distribution, installation, training, and ongoing technical support in Costa Rica. SOLME is a registered supplier to the Caja Costarricense de Seguro Social (CCSS), the country's principal purchaser and provider of hospital services. This relationship could facilitate adoption of the Nanox.ARC within Costa Rica's public healthcare system, potentially accelerating the technology's reach to a broader patient population.
Commercialization will follow applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration. This phased approach allows for clinical validation and adaptation to local requirements, which is critical for gaining acceptance from healthcare providers and regulators. The proof-of-concept period may also serve as a demonstration of the system's capabilities, helping to build confidence among stakeholders.
The expansion into Costa Rica is part of Nanox's broader vision to drive the world's transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform. The company combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care. By integrating these components, Nanox aims to lower barriers to adoption and improve utilization of medical imaging, particularly in underserved areas.
The Nanox ecosystem includes several key components. The Nanox.ARC is a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability. Nanox.AI is a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease. Nanox.CLOUD provides a cloud-based platform for secure data management, storage, and advanced imaging analytics. Nanox.MARKETPLACE and USARAD Holdings offer access to remote radiology and cardiology experts and comprehensive teleradiology services. Nanox Health IT combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.
For Costa Rica, the agreement could mean improved access to advanced imaging services, which are essential for early detection and management of diseases. The CCSS, as the primary public healthcare provider, serves a large portion of the population, and the introduction of Nanox.ARC could enhance diagnostic capabilities in hospitals and clinics. This aligns with global efforts to make medical imaging more accessible and affordable, particularly in emerging markets.
Nanox's forward-looking statements note that the commercialization is subject to risks and uncertainties, including regulatory approvals and market acceptance. However, the company's track record of expanding into new markets and its integrated approach may position it well for success. The latest news and updates relating to NNOX are available in the company's newsroom at https://ibn.fm/NNOX. For full terms of use and disclaimers, visit https://IBN.ai/Disclaimer. To view the full press release, visit https://ibn.fm/C77lJ.
